| 2024/04/18 08:02:30 | |
|---|---|
| Price | |
| 8.818 EUR | |
| Difference | -0.43% (-0.04) |
General attributes
| ISIN | JP3942400007 |
| Symbol | 4503 |
| Exchange | Stuttgart |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 16,151 EUR |
| Benchmark | NIKKEI 225 |
Market data
| Bid (Bid size) | 8.88 EUR (1,000) |
| Ask (Ask size) | 9.036 EUR (1,000) |
| Open | 8.818 EUR |
| High | 8.818 EUR |
| Low | 8.818 EUR |
| Close (prev. day) | 8.856 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: ASTELLAS PHARMA INC. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/18 08:02:30 | |
|---|---|
| Price | |
| 8.818 EUR | |
| Difference | -0.43% (-0.04) |
General attributes
| ISIN | JP3942400007 |
| Symbol | 4503 |
| Exchange | Stuttgart |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 16,151 EUR |
| Benchmark | NIKKEI 225 |
Market data
| Bid (Bid size) | 8.88 EUR (1,000) |
| Ask (Ask size) | 9.036 EUR (1,000) |
| Open | 8.818 EUR |
| High | 8.818 EUR |
| Low | 8.818 EUR |
| Close (prev. day) | 8.856 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -26.81% | -34.18% | -29.49% |
| Perf (abs.) | -3.24 | -4.60 | -3.70 |
| Beta | 0.37 | 0.59 | 0.62 |
| Volatility | 31.20 | 29.70 | 27.05 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 8.981 EUR (780) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 9.718 EUR (353) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 10.364 EUR (325) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 12.178 EUR (185) |
| YTD High | date | 11.405 EUR (2024/01/16) |
| YTD Low | date | 8.734 EUR (2024/04/15) |
| 52 Weeks High | date | 15.495 EUR (2023/05/25) |
| 52 Weeks Low | date | 8.734 EUR (2024/04/15) |
All listings for ASTELLAS PHARMA INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/04/17 | 22:26 | 8.862 EUR | 0.02 | 5 |
| Tokyo Stock Exchange | 2024/04/17 | 08:00 | 1,466.50 JPY | 144.87 | 7,250 |
| Stuttgart | 2024/04/18 | 08:02 | 8.818 EUR | 0.00 | 1 |
| Munich | 2024/04/18 | 08:02 | 8.906 EUR | 0.00 | 1 |
| Frankfurt | 2024/04/17 | 21:50 | 8.656 EUR | 0.00 | 3 |
| FINRA other OTC Issues | 2024/04/16 | 18:49 | 9.594 USD | 0.02 | 5 |
| Duesseldorf | 2024/04/18 | 08:10 | 8.80 EUR | 0.00 | 1 |
| Berlin | 2024/04/18 | 09:15 | 8.97 EUR | 0.00 | 2 |
Company Logo
Contact Details
| ASTELLAS PHARMA INC. |
| - - |
| 2-5-1 Nihonbashi-Honcho, Chuo-Ku - 103-8411 Tokyo |
| Telefon: +81-3-3244-3000 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: ASTELLAS PHARMA INC. | |
Company Profile
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan. |
Members of Management Board
| Kenji Yasukawa | Chairman of Managing Board |
| Bernie Zeiher | Member of Executive Committee |
| Catherine Levitt | Member of Executive Committee |
| Fumiaki Sakurai | Member of Executive Committee |
| Hideki Shima | Member of Executive Committee |
| Minoru Kikuoka | Member of Executive Committee |
| Naoki Okamura | Member of Executive Committee |
| Yoshihtsugu Shitaka | Member of Executive Committee |
| Yukio Matsui | Member of Executive Committee |
Board of directors
| Kenji Yasukawa | Chairman of Supervisory Board |
| Eriko Sakurai | Member of Supervisory Board |
| Haruko Shibumura | Member of Supervisory Board |
| Hiroko Sakai | Member of Supervisory Board |
| Hiroo Sasaki | Member of Supervisory Board |
| Hiroshi Kawabe | Member of Supervisory Board |
| Katsuyoshi Sugita | Member of Supervisory Board |
| Mamoru Sekiyama | Member of Supervisory Board |
| Mika Nakayama | Member of Supervisory Board |
| Noriyuki Uematsu | Member of Supervisory Board |
| Takashi Tanaka | Member of Supervisory Board |
| Tatsuro Ishizuka | Member of Supervisory Board |
| Tomokazu Fujisawa | Member of Supervisory Board |